Pharmacia Corporation & Ors v Merck & Co Inc & Anor [2001] EWCA Civ 1957 (14 December, 2001)
Given the complexity and propriety of the issue argued by the appellants, the respondents should not recover full costs; a 10% reduction is appropriate, so respondents recover 90% of their costs in this court.
- Citation
- [2001] EWCA Civ 1957
- Parties
- Claimant/appellant: Pharmacia Corporation; Claimant/appellant: GD Searle & Co; Claimant/appellant: Pfizer Inc; Defendant/respondent: Merck & Co Inc; Defendant/respondent: Merck Sharp & Dohme Limited
- Jurisdiction
- England and Wales
- Procedural Posture
- Appeal / Court of Appeal Judgment on Costs
- Outcome
- Appeal dismissed; permission to appeal to the House of Lords refused.
- Legal Topics
- Costs, Patents, Appeal Procedure
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Pharmacia Corporation
Claimant/appellant
GD Searle & Co
Claimant/appellant
Pfizer Inc
Claimant/appellant
Merck & Co Inc
Defendant/respondent
Merck Sharp & Dohme Limited
Defendant/respondent
Procedural Posture
Appeal / Court of Appeal Judgment on Costs
Legal Issues
- 1 Appropriate order for costs in a complex patent action on appeal
Ratio Decidendi
Given the complexity and propriety of the issue argued by the appellants, the respondents should not recover full costs; a 10% reduction is appropriate, so respondents recover 90% of their costs in this court.
Court Disposition
Appeal dismissed; permission to appeal to the House of Lords refused.
Orders
- Appellants to pay 90% of the respondents' costs in this court.
- Order of the judge on costs reduced by 10%.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment